Include Page

DiaKine Therapeutics, Inc. is a development-stage company commercializing novel immune anti-inflamatory modulators into therapies for diabetes and related complications. These drugs have the potential to stop the progression of diabetes and reverse damage already caused by the disease. 

Therapeutics under development by DiaKine include:

·         Adjunct to islet cell transplants

·         Halt the progression of type 1 diabetes in newly diagnosed adults.

·         Treatment and prevention of insulin requiring type 2 diabetic

·         Treatment and prevention of diabetes complications

·         Treatment to halt inflammation linked to atherosclerosis and autoimmune disease

For more information, please contact us at info@diakine.com.


 


DiaKine Therapeutics • 338 Raleigh Ave. • Norfolk VA 23507 •info@diakine.com

©2012 DiaKine Therapeutics. All rights reserved.
Web site designed, developed and hosted by Atlanta Web Service LLC.
For technical questions or comments about this site, contact the Webmaster.